| A controlled trial of erenumab for episodic migraine PJ Goadsby, U Reuter, Y Hallström, G Broessner, JH Bonner, F Zhang, ... New England Journal of Medicine 377 (22), 2123-2132, 2017 | 909 | 2017 |
| Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial S Tepper, M Ashina, U Reuter, JL Brandes, D Doležil, S Silberstein, ... The Lancet Neurology 16 (6), 425-434, 2017 | 781 | 2017 |
| Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study CW Olanow, K Kieburtz, P Odin, AJ Espay, DG Standaert, HH Fernandez, ... The Lancet Neurology 13 (2), 141-149, 2014 | 720 | 2014 |
| ARISE: a phase 3 randomized trial of erenumab for episodic migraine DW Dodick, M Ashina, JL Brandes, D Kudrow, M Lanteri-Minet, V Osipova, ... Cephalalgia 38 (6), 1026-1037, 2018 | 558 | 2018 |
| Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial H Sun, DW Dodick, S Silberstein, PJ Goadsby, U Reuter, M Ashina, ... The Lancet Neurology 15 (4), 382-390, 2016 | 396 | 2016 |
| Erenumab in chronic migraine with medication overuse: subgroup analysis of a randomized trial SJ Tepper, HC Diener, M Ashina, JL Brandes, DI Friedman, U Reuter, ... Neurology 92 (20), e2309-e2320, 2019 | 209 | 2019 |
| Erenumab (AMG 334) in episodic migraine: interim analysis of an ongoing open-label study M Ashina, D Dodick, PJ Goadsby, U Reuter, S Silberstein, F Zhang, ... Neurology 89 (12), 1237-1243, 2017 | 147 | 2017 |
| Retrograde signalling in depolarization‐induced suppression of inhibition in rat hippocampal CA1 cells. BE Alger, TA Pitler, JJ Wagner, LA Martin, W Morishita, SA Kirov, RA Lenz The Journal of physiology 496 (1), 197-209, 1996 | 145 | 1996 |
| Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: a subgroup analysis of a randomized, double-blind, placebo … M Ashina, S Tepper, JL Brandes, U Reuter, G Boudreau, D Dolezil, ... Cephalalgia 38 (10), 1611-1621, 2018 | 140 | 2018 |
| A randomized, double‐blind, placebo‐controlled study to evaluate the effect of erenumab on exercise time during a treadmill test in patients with stable angina C Depre, L Antalik, A Starling, M Koren, O Eisele, RA Lenz, DD Mikol Headache: The Journal of Head and Face Pain 58 (5), 715-723, 2018 | 136 | 2018 |
| Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results HH Fernandez, A Vanagunas, P Odin, AJ Espay, RA Hauser, ... Parkinsonism & related disorders 19 (3), 339-345, 2013 | 110 | 2013 |
| Erenumab in chronic migraine: patient-reported outcomes in a randomized double-blind study RB Lipton, SJ Tepper, U Reuter, S Silberstein, WF Stewart, J Nilsen, ... Neurology 92 (19), e2250-e2260, 2019 | 96 | 2019 |
| N-and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells RA Lenz, JJ Wagner, BE Alger The Journal of Physiology 512 (Pt 1), 61, 1998 | 90 | 1998 |
| Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab DC Buse, RB Lipton, Y Hallström, U Reuter, SJ Tepper, F Zhang, S Sapra, ... Cephalalgia 38 (10), 1622-1631, 2018 | 79 | 2018 |
| A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia GM Haig, Y Pritchett, A Meier, AA Othman, C Hall, LM Gault, RA Lenz Journal of Alzheimer's Disease 42 (3), 959-971, 2014 | 79 | 2014 |
| Migraine prophylaxis and acute treatment patterns among commercially insured patients in the United States JM Woolley, MM Bonafede, BA Maiese, RA Lenz Headache: The Journal of Head and Face Pain 57 (9), 1399-1408, 2017 | 70 | 2017 |
| A randomized phase 2 study of erenumab for the prevention of episodic migraine in Japanese adults F Sakai, T Takeshima, Y Tatsuoka, K Hirata, R Lenz, Y Wang, S Cheng, ... Headache: The Journal of Head and Face Pain 59 (10), 1731-1742, 2019 | 69 | 2019 |
| High intracellular Cl− concentrations depress G-protein-modulated ionic conductances RA Lenz, TA Pitler, BE Alger Journal of Neuroscience 17 (16), 6133-6141, 1997 | 68 | 1997 |
| Calcium dependence of depolarization‐induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons RA Lenz, BE Alger The Journal of Physiology 521 (1), 147-157, 1999 | 67 | 1999 |
| Therapeutic monoclonal antibodies: what headache specialists need to know S Silberstein, R Lenz, C Xu Headache: The Journal of Head and Face Pain 55 (8), 1171-1182, 2015 | 66 | 2015 |
